|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Stock-based compensation expense | |||||
| Loss on extinguishment of revolving credit line | |||||
| Amortization of intangible assets | |||||
| Amortization of costs capitalized to obtain revenue contracts | |||||
| Depreciation and amortization | |||||
| Depreciation expense | |||||
| Bad debt expense | |||||
| Amortization of investment premiums & other | |||||
| Accretion and amortization on debt securities | |||||
| Net changes in estimated fair value of acquisition-related contingent consideration | |||||
| Deferred taxes | |||||
| Changes in assets and liabilities, net of acquisitions: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued payroll and related taxes | |||||
| Income taxes payable | |||||
| Deferred revenue | |||||
| Restructuring accrual | |||||
| Other liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing activities: | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Sales of investments | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of property and equipment, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Proceeds from the issuance of convertible senior notes | |||||
| Payment for convertible senior notes issuance costs | |||||
| Purchase of 2026 convertible senior notes hedge | |||||
| Proceeds from issuance of convertible senior notes warrants | |||||
| Payment of debt issuance costs | |||||
| Proceeds from the issuance of equity plan common stock | |||||
| Repurchases and retirements of common stock | |||||
| Payment of acquisition-related contingent consideration | |||||
| Proceeds from other borrowings | |||||
| Principal payments on other borrowings | |||||
| Net cash provided by (used in) financing activities | |||||
| Foreign currency effect on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Reclassification of convertible senior notes hedge and embedded conversion derivative to additional paid-in capital | |||||
| Acquisition-related shares issued | |||||
| Unrealized holding gain (loss) on available-for-sale investments |
Loading...